Given the well-established heterogeneity of colorectal cancer based on tumor location—with distinct embryological origins, molecular pathways, histological features, and metastatic patterns—the assessment of SIRT1 polymorphisms in relation to tumor site may provide additional insights into their role in CRC pathogenesis. This evidence concerns the gene SIRT1 and colorectal cancer.